Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
PharmaVoice,
Positive results outperformed standard of care with prolonged overall survival and progression-free survival in patients with…